Ancillary cell help in haematopoietic cord blood engraftment
Cord blood (CB) has served as a source of haematopoietic stem cells (HSC) to treat haematological diseases for the last two decades. Low incidence and severity of graft-versus-host disease, and a robust graft-versus-leukaemia effect are some of CB advantages as a source for HSC. However, its main di...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626844 |